Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States
Recommendations from the U.S. Department of Health and Human Services
Dawn K. Smith, MD1
Lisa A. Grohskopf, MD1
Roberta J. Black, PhD2
Judith D. Auerbach, PhD2
Fulvia Veronese, PhD2
Kimberly A. Struble, PharmD3
Laura Cheever, MD4
Michael Johnson, MD4
Lynn A. Paxton, MD1
Ida M. Onorato, MD1
Alan E. Greenberg, MD1
1Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, CDC, Atlanta, Georgia
2National Institutes of Health
3Food and Drug Administration, Washington, D.C.
4Health Resources and Services Administration
The material presented in this report originated in the Division of HIV/AIDS
Prevention, National Center for HIV, STD, and TB Prevention, Janet L. Collins, MD, Acting Director.
Corresponding Author : Lisa A. Grohskopf, MD, Epidemiology Branch, Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, CDC, 1600 Clifton Road NE, MS-E45, Atlanta, GA 30333. Telephone : 404-639-6116 ; Fax : 404-639-6127 ; e-mail : email@example.com.
Full text au format PDF